| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 58 companies in the Health Care Technology industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 17, 2023 | PHR Phreesia, Inc. | Roberts Evan71 | Chief Operating Officer | Sell | 2,600 | $32.01 | $83,228.86 | -0.4% | +4.6% | -28.2% | |
| Apr 17, 2023 | PHR Phreesia, Inc. | Vanduyn Amy Beth65 | SVP, Human Resources | Sell | 570 | $31.84 | $18,148.86 | -0.5% | +4.6% | -28.2% | |
| Apr 17, 2023 | PHR Phreesia, Inc. | Gandhi Balaji69 | Chief Financial Officer | Sell | 2,113 | $31.83 | $67,247.92 | -2.4% | +4.6% | -28.2% | |
| Apr 14, 2023 | TXG 10x Genomics, Inc. | Saxonov Serge80 | Chief Executive Officer | Sell | 2,000 | $53.82 | $107,639.93 | - | +6.6% | -36.1% | |
| Apr 14, 2023 | PHR Phreesia, Inc. | Hoffman Allison C66 | General Counsel &Secretary | Sell | 3,306 | $31.16 | $103,017.27 | -2.5% | +3.7% | -25.5% | |
| Apr 14, 2023 | CERT Certara, Inc. | Traynor Richard M.80 | SVP And General Counsel | Sell | 5,000 | $23.66 | $118,300.00 | -2.7% | -21.8% | -26.7% | |
| Apr 14, 2023 | PRVA Privia Health Group, Inc. | Sullivan William M74 | Director | Sell | 18,153 | $25.14 | $456,366.42 | -0.3% | +1.6% | -25.0% | |
| Apr 12, 2023 | PHR Phreesia, Inc. | Roberts Evan71 | Chief Operating Officer | Sell | 200 | $32.01 | $6,402.00 | - | +4.0% | -21.7% | |
| Apr 12, 2023 | PRVA Privia Health Group, Inc. | Mehrotra Parth75 | President And COO | Sell | 1,500 | $28.08 | $42,120.00 | -1.5% | -6.6% | -31.9% | |
| Apr 12, 2023 | PRVA Privia Health Group, Inc. | Morris Matthew Shawn78 | Chief Executive Officer | Sell | 26,056 | $28.11 | $732,404.16 | -9.7% | -6.6% | -31.9% | |
| Apr 11, 2023 | DOCS Doximity, Inc. | Cabral Timothy S58 | Director | Sell | 7,500 | $35.00 | $262,500.00 | -61.4% | -4.5% | -26.6% | |
| Apr 11, 2023 | PHR Phreesia, Inc. | Davidoff Michael J.65 | SVP, Payer Business | Sell | 3,466 | $30.91 | $107,123.66 | -3.4% | -2.1% | -25.2% | |
| Apr 11, 2023 | PRVA Privia Health Group, Inc. | Mehrotra Parth75 | President And COO | Sell | 34,206 | $28.10 | $961,159.60 | -14.9% | -9.3% | -33.7% | |
| Apr 10, 2023 | MGRX Mangoceuticals, Inc. | Cohen Jacob D. | Chief Executive Officer | Buy | 275,000 | $1.00 | $275,000.00 | +3.4% | +91.3% | -69.3% | |
| Apr 5, 2023 | PRVA Privia Health Group, Inc. | Mehrotra Parth75 | President And COO | Sell | 22,604 | $28.04 | $633,816.16 | -18.8% | -7.3% | -33.8% | |
| Apr 4, 2023 | PRVA Privia Health Group, Inc. | Morris Matthew Shawn78 | Chief Executive Officer | Sell | 7,076 | $28.06 | $198,552.56 | -5.5% | -8.8% | -35.0% | |
| Apr 4, 2023 | PRVA Privia Health Group, Inc. | Mehrotra Parth75 | President And COO | Sell | 24,295 | $28.08 | $682,154.08 | -11.1% | -8.8% | -35.0% | |
| Apr 3, 2023 | EVH Evolent Health, Inc. | Williams Frank J56 | Director | Sell | 110,000 | $31.83 | $3,501,348.18 | -6.3% | -6.4% | -5.6% | |
| Apr 3, 2023 | PRVA Privia Health Group, Inc. | Mountcastle David70 | EVP &Chief Financial Officer | Sell | 5,506 | $27.62 | $152,075.72 | -3.5% | -7.8% | -34.8% | |
| Apr 3, 2023 | PHR Phreesia, Inc. | Smith Mark Douglas68 | Director | Sell | 7,000 | $30.77 | $215,367.25 | -17.6% | -1.1% | -25.3% | |
| Apr 3, 2023 | PRVA Privia Health Group, Inc. | Bartrum Thomas70 | EVP, General Counsel | Sell | 15,000 | $27.59 | $413,850.00 | -14.1% | -7.8% | -34.8% | |
| Apr 3, 2023 | DOCS Doximity, Inc. | Cabral Timothy S58 | Director | Sell | 10,000 | $32.00 | $319,955.00 | -68.0% | +4.5% | -18.1% | |
| Apr 3, 2023 | PHR Phreesia, Inc. | Vanduyn Amy Beth65 | SVP, Human Resources | Sell | 2,978 | $30.79 | $91,696.61 | -1.5% | -1.1% | -25.3% | |
| Apr 3, 2023 | NRC National Research Corp | Raasch Jona S61 | COO, Nrc Health | Sell | 23,931 | $43.61 | $1,043,512.26 | -71.2% | -1.2% | -18.1% | |
| Mar 30, 2023 | NRC National Research Corp | Raasch Jona S61 | COO, Nrc Health | Sell | 25,000 | $43.49 | $1,087,261.50 | -27.4% | +1.8% | -7.1% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.